177 related articles for article (PubMed ID: 6130520)
21. Cyclic nucleotides and their associated enzymes in 9,10-dimethyl-1,2-benzanthracene-induced mammary tumors of rats.
Rillema JA; Mulder JA; Anderson LD
Cancer Res; 1978 Mar; 38(3):741-4. PubMed ID: 23896
[No Abstract] [Full Text] [Related]
22. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
Polson JB; Krzanowski JJ; Goldman AL; Szentivanyi A
Allergol Immunopathol (Madr); 1982; 10(2):101-4. PubMed ID: 6125092
[TBL] [Abstract][Full Text] [Related]
23. Effects of Ca2+ and calmodulin on cyclic nucleotide metabolism in neurosecretosomes isolated from ox neurohypophyses.
Dartt DA; Torp-Pedersen C; Thorn NA
Brain Res; 1981 Jan; 204(1):121-8. PubMed ID: 6113872
[TBL] [Abstract][Full Text] [Related]
24. [The cyclic nucleotide system in various sections of the dog myocardium in experimental infarction].
Frolova NIu; Printsev MD; Tret'iakov AV; Kozhetiakin LA; Korovkin BF
Vopr Med Khim; 1989; 35(1):64-8. PubMed ID: 2568032
[TBL] [Abstract][Full Text] [Related]
25. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
26. Theoretical analyses of the functioning of the high- and low-Km cyclic nucleotide phosphodiesterases in the regulation of the concentration of adenosine 3',5'-cyclic monophosphate in animal cells.
Fell DA
J Theor Biol; 1980 May; 84(2):361-85. PubMed ID: 6251314
[No Abstract] [Full Text] [Related]
27. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
28. Altered levels of cyclic nucleotides, cyclic AMP phosphodiesterase and adenylyl cyclase activities in normal, dysplastic and neoplastic human mammary tissue.
Küng W; Bechtel E; Geyer E; Salokangas A; Preisz J; Huber P; Torhorst J; Jungmann RA; Talmadge K; Eppenberger U
FEBS Lett; 1977 Oct; 82(1):102-6. PubMed ID: 199454
[No Abstract] [Full Text] [Related]
29. Cyclic nucleotides in stroke and related cerebrovascular disorders.
Palmer GC
Life Sci; 1985 May; 36(21):1995-2006. PubMed ID: 2860549
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
[No Abstract] [Full Text] [Related]
31. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig.
Johnson WB; Katugampola S; Able S; Napier C; Harding SE
Life Sci; 2012 Feb; 90(9-10):328-36. PubMed ID: 22261303
[TBL] [Abstract][Full Text] [Related]
32. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
Grewal J; Karuppiah N; Mutus B
Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
[TBL] [Abstract][Full Text] [Related]
33. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
35. [Adenylate- and guanylate cyclase systems in pathology of the adrenal glands].
Iudaev NA; Afinogenova SA; Chekhranova MK; Makarovskaia EE; Smirnova NB
Probl Endokrinol (Mosk); 1985; 31(5):31-6. PubMed ID: 2866510
[TBL] [Abstract][Full Text] [Related]
36. [The role of the components of the cyclic nucleotide system in N-nitrosodiethylamine-induced hepatic carcinogenesis in rats].
Antonenko SG; Berdinskikh NK; Mishnaevskaia EG
Eksp Onkol; 1990; 12(5):18-21. PubMed ID: 2171896
[TBL] [Abstract][Full Text] [Related]
37. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
38. Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells.
Côté M; Payet MD; Rousseau E; Guillon G; Gallo-Payet N
Endocrinology; 1999 Aug; 140(8):3594-601. PubMed ID: 10433216
[TBL] [Abstract][Full Text] [Related]
39. The newborn mouse as a model for study of the effects of hormonal steroids in the young.
Kohrman AF
Pediatrics; 1978 Dec; 62(6 Pt 2):1143-50. PubMed ID: 31596
[No Abstract] [Full Text] [Related]
40. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
